Global and United States Mono Hepatitis A Vaccine Market Insights, Forecast to 2027

Publisher Name :
Date: 24-Dec-2021
No. of pages: 145
Inquire Before Buying

Mono Hepatitis A Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Mono Hepatitis A Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Mono Hepatitis A Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Inactivated Vaccine

- Live Attenuated Vaccine

Segment by Application

- Government Institution

- Private Sector

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- GSK

- Merck

- Sanofi

- Sinovac

- Zhejiang Pukang

- Changchun Institute of Biological

- Kaketsuken

- IMBCA

- ChangSheng

- Convac

Global and United States Mono Hepatitis A Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Mono Hepatitis A Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Mono Hepatitis A Vaccine Market Size Growth Rate by Type
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Mono Hepatitis A Vaccine Market Size Growth Rate by Application
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mono Hepatitis A Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Mono Hepatitis A Vaccine Revenue 2016-2027
2.1.2 Global Mono Hepatitis A Vaccine Sales 2016-2027
2.2 Global Mono Hepatitis A Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Mono Hepatitis A Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Mono Hepatitis A Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Mono Hepatitis A Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Mono Hepatitis A Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Mono Hepatitis A Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Mono Hepatitis A Vaccine Revenue Forecast by Region (2022-2027)
3 Global Mono Hepatitis A Vaccine Competitor Landscape by Players
3.1 Global Top Mono Hepatitis A Vaccine Manufacturers by Sales
3.1.1 Global Mono Hepatitis A Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Mono Hepatitis A Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Mono Hepatitis A Vaccine Manufacturers by Revenue
3.2.1 Key Mono Hepatitis A Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Mono Hepatitis A Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Mono Hepatitis A Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Mono Hepatitis A Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Mono Hepatitis A Vaccine Revenue in 2020
3.2.6 Global Mono Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Mono Hepatitis A Vaccine Price by Manufacturers
3.4 Global Mono Hepatitis A Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Mono Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mono Hepatitis A Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Mono Hepatitis A Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Mono Hepatitis A Vaccine Market Size by Type (2016-2021)
4.1.1 Global Mono Hepatitis A Vaccine Sales by Type (2016-2021)
4.1.2 Global Mono Hepatitis A Vaccine Revenue by Type (2016-2021)
4.1.3 Mono Hepatitis A Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Mono Hepatitis A Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Mono Hepatitis A Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Mono Hepatitis A Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Mono Hepatitis A Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Mono Hepatitis A Vaccine Market Size by Application (2016-2021)
5.1.1 Global Mono Hepatitis A Vaccine Sales by Application (2016-2021)
5.1.2 Global Mono Hepatitis A Vaccine Revenue by Application (2016-2021)
5.1.3 Mono Hepatitis A Vaccine Price by Application (2016-2021)
5.2 Mono Hepatitis A Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Mono Hepatitis A Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Mono Hepatitis A Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Mono Hepatitis A Vaccine Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Mono Hepatitis A Vaccine Market Size YoY Growth 2016-2027
6.1.1 United States Mono Hepatitis A Vaccine Sales YoY Growth 2016-2027
6.1.2 United States Mono Hepatitis A Vaccine Revenue YoY Growth 2016-2027
6.1.3 United States Mono Hepatitis A Vaccine Market Share in Global Market 2016-2027
6.2 United States Mono Hepatitis A Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Mono Hepatitis A Vaccine Players by Sales (2016-2021)
6.2.2 United States Top Mono Hepatitis A Vaccine Players by Revenue (2016-2021)
6.3 United States Mono Hepatitis A Vaccine Historic Market Review by Type (2016-2021)
6.3.1 United States Mono Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
6.3.2 United States Mono Hepatitis A Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 United States Mono Hepatitis A Vaccine Price by Type (2016-2021)
6.4 United States Mono Hepatitis A Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Mono Hepatitis A Vaccine Sales Forecast by Type (2022-2027)
6.4.2 United States Mono Hepatitis A Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 United States Mono Hepatitis A Vaccine Price Forecast by Type (2022-2027)
6.5 United States Mono Hepatitis A Vaccine Historic Market Review by Application (2016-2021)
6.5.1 United States Mono Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
6.5.2 United States Mono Hepatitis A Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 United States Mono Hepatitis A Vaccine Price by Application (2016-2021)
6.6 United States Mono Hepatitis A Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Mono Hepatitis A Vaccine Sales Forecast by Application (2022-2027)
6.6.2 United States Mono Hepatitis A Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 United States Mono Hepatitis A Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Mono Hepatitis A Vaccine Market Size YoY Growth 2016-2027
7.2 North America Mono Hepatitis A Vaccine Market Facts & Figures by Country
7.2.1 North America Mono Hepatitis A Vaccine Sales by Country (2016-2021)
7.2.2 North America Mono Hepatitis A Vaccine Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Mono Hepatitis A Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Mono Hepatitis A Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Mono Hepatitis A Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Mono Hepatitis A Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Mono Hepatitis A Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Mono Hepatitis A Vaccine Market Facts & Figures by Country
9.2.1 Europe Mono Hepatitis A Vaccine Sales by Country (2016-2021)
9.2.2 Europe Mono Hepatitis A Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Mono Hepatitis A Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Mono Hepatitis A Vaccine Market Facts & Figures by Country
10.2.1 Latin America Mono Hepatitis A Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Mono Hepatitis A Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Mono Hepatitis A Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Mono Hepatitis A Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Mono Hepatitis A Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Mono Hepatitis A Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Mono Hepatitis A Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Mono Hepatitis A Vaccine Products Offered
12.2.5 Merck Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Description and Business Overview
12.3.3 Sanofi Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Mono Hepatitis A Vaccine Products Offered
12.3.5 Sanofi Recent Development
12.4 Sinovac
12.4.1 Sinovac Corporation Information
12.4.2 Sinovac Description and Business Overview
12.4.3 Sinovac Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sinovac Mono Hepatitis A Vaccine Products Offered
12.4.5 Sinovac Recent Development
12.5 Zhejiang Pukang
12.5.1 Zhejiang Pukang Corporation Information
12.5.2 Zhejiang Pukang Description and Business Overview
12.5.3 Zhejiang Pukang Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Zhejiang Pukang Mono Hepatitis A Vaccine Products Offered
12.5.5 Zhejiang Pukang Recent Development
12.6 Changchun Institute of Biological
12.6.1 Changchun Institute of Biological Corporation Information
12.6.2 Changchun Institute of Biological Description and Business Overview
12.6.3 Changchun Institute of Biological Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Changchun Institute of Biological Mono Hepatitis A Vaccine Products Offered
12.6.5 Changchun Institute of Biological Recent Development
12.7 Kaketsuken
12.7.1 Kaketsuken Corporation Information
12.7.2 Kaketsuken Description and Business Overview
12.7.3 Kaketsuken Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Kaketsuken Mono Hepatitis A Vaccine Products Offered
12.7.5 Kaketsuken Recent Development
12.8 IMBCA
12.8.1 IMBCA Corporation Information
12.8.2 IMBCA Description and Business Overview
12.8.3 IMBCA Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 IMBCA Mono Hepatitis A Vaccine Products Offered
12.8.5 IMBCA Recent Development
12.9 ChangSheng
12.9.1 ChangSheng Corporation Information
12.9.2 ChangSheng Description and Business Overview
12.9.3 ChangSheng Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ChangSheng Mono Hepatitis A Vaccine Products Offered
12.9.5 ChangSheng Recent Development
12.10 Convac
12.10.1 Convac Corporation Information
12.10.2 Convac Description and Business Overview
12.10.3 Convac Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Convac Mono Hepatitis A Vaccine Products Offered
12.10.5 Convac Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Mono Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Mono Hepatitis A Vaccine Products Offered
12.11.5 GSK Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Mono Hepatitis A Vaccine Industry Trends
13.2 Mono Hepatitis A Vaccine Market Drivers
13.3 Mono Hepatitis A Vaccine Market Challenges
13.4 Mono Hepatitis A Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mono Hepatitis A Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Mono Hepatitis A Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Live Attenuated Vaccine
Table 4. Global Mono Hepatitis A Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Mono Hepatitis A Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Mono Hepatitis A Vaccine Sales by Regions (2016-2021) & (K Units)
Table 7. Global Mono Hepatitis A Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global Mono Hepatitis A Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Mono Hepatitis A Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Mono Hepatitis A Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Mono Hepatitis A Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Mono Hepatitis A Vaccine Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Mono Hepatitis A Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Mono Hepatitis A Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Mono Hepatitis A Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Mono Hepatitis A Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Mono Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Mono Hepatitis A Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mono Hepatitis A Vaccine as of 2020)
Table 20. Key Manufacturers Mono Hepatitis A Vaccine Price (2016-2021) (US$/Unit)
Table 21. Mono Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Mono Hepatitis A Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Mono Hepatitis A Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Mono Hepatitis A Vaccine Sales by Type (2016-2021) (K Units)
Table 26. Global Mono Hepatitis A Vaccine Sales Share by Type (2016-2021)
Table 27. Global Mono Hepatitis A Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Mono Hepatitis A Vaccine Revenue Share by Type (2016-2021)
Table 29. Mono Hepatitis A Vaccine Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Mono Hepatitis A Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Mono Hepatitis A Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Mono Hepatitis A Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Mono Hepatitis A Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Mono Hepatitis A Vaccine Sales by Application (2016-2021) (K Units)
Table 36. Global Mono Hepatitis A Vaccine Sales Share by Application (2016-2021)
Table 37. Global Mono Hepatitis A Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Mono Hepatitis A Vaccine Revenue Share by Application (2016-2021)
Table 39. Mono Hepatitis A Vaccine Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Mono Hepatitis A Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Mono Hepatitis A Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Mono Hepatitis A Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Mono Hepatitis A Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. United States Mono Hepatitis A Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 46. United States Mono Hepatitis A Vaccine Sales Share by Company (2016-2021)
Table 47. United States Mono Hepatitis A Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Mono Hepatitis A Vaccine Revenue Share by Company (2016-2021)
Table 49. United States Mono Hepatitis A Vaccine Sales (K Units) by Type (2016-2021)
Table 50. United States Mono Hepatitis A Vaccine Sales Share by Type (2016-2021)
Table 51. United States Mono Hepatitis A Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Mono Hepatitis A Vaccine Price (US$/Unit) by Type (2016-2021)
Table 53. United States Mono Hepatitis A Vaccine Sales (K Units) by Type (2022-2027)
Table 54. United States Mono Hepatitis A Vaccine Sales Share by Type (2022-2027)
Table 55. United States Mono Hepatitis A Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Mono Hepatitis A Vaccine Revenue Share by Type (2022-2027)
Table 57. United States Mono Hepatitis A Vaccine Price (US$/Unit) by Type (2022-2027)
Table 58. United States Mono Hepatitis A Vaccine Sales (K Units) by Application (2016-2021)
Table 59. United States Mono Hepatitis A Vaccine Sales Share by Application (2016-2021)
Table 60. United States Mono Hepatitis A Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Mono Hepatitis A Vaccine Price (US$/Unit) by Application (2016-2021)
Table 62. United States Mono Hepatitis A Vaccine Sales (K Units) by Application (2022-2027)
Table 63. United States Mono Hepatitis A Vaccine Sales Share by Application (2022-2027)
Table 64. United States Mono Hepatitis A Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Mono Hepatitis A Vaccine Revenue Share by Application (2022-2027)
Table 66. United States Mono Hepatitis A Vaccine Price (US$/Unit) by Application (2022-2027)
Table 67. North America Mono Hepatitis A Vaccine Sales by Country (2016-2021) & (K Units)
Table 68. North America Mono Hepatitis A Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America Mono Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Mono Hepatitis A Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Mono Hepatitis A Vaccine Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Mono Hepatitis A Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Mono Hepatitis A Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Mono Hepatitis A Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe Mono Hepatitis A Vaccine Sales by Country (2016-2021) & (K Units)
Table 76. Europe Mono Hepatitis A Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe Mono Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Mono Hepatitis A Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Mono Hepatitis A Vaccine Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Mono Hepatitis A Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Mono Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Mono Hepatitis A Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Mono Hepatitis A Vaccine Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Mono Hepatitis A Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Mono Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Mono Hepatitis A Vaccine Revenue Market Share by Country (2016-2021)
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. GSK Mono Hepatitis A Vaccine Product
Table 91. GSK Recent Development
Table 92. Merck Corporation Information
Table 93. Merck Description and Business Overview
Table 94. Merck Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Merck Product
Table 96. Merck Recent Development
Table 97. Sanofi Corporation Information
Table 98. Sanofi Description and Business Overview
Table 99. Sanofi Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Sanofi Product
Table 101. Sanofi Recent Development
Table 102. Sinovac Corporation Information
Table 103. Sinovac Description and Business Overview
Table 104. Sinovac Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Sinovac Product
Table 106. Sinovac Recent Development
Table 107. Zhejiang Pukang Corporation Information
Table 108. Zhejiang Pukang Description and Business Overview
Table 109. Zhejiang Pukang Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Zhejiang Pukang Product
Table 111. Zhejiang Pukang Recent Development
Table 112. Changchun Institute of Biological Corporation Information
Table 113. Changchun Institute of Biological Description and Business Overview
Table 114. Changchun Institute of Biological Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Changchun Institute of Biological Product
Table 116. Changchun Institute of Biological Recent Development
Table 117. Kaketsuken Corporation Information
Table 118. Kaketsuken Description and Business Overview
Table 119. Kaketsuken Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Kaketsuken Product
Table 121. Kaketsuken Recent Development
Table 122. IMBCA Corporation Information
Table 123. IMBCA Description and Business Overview
Table 124. IMBCA Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. IMBCA Product
Table 126. IMBCA Recent Development
Table 127. ChangSheng Corporation Information
Table 128. ChangSheng Description and Business Overview
Table 129. ChangSheng Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. ChangSheng Product
Table 131. ChangSheng Recent Development
Table 132. Convac Corporation Information
Table 133. Convac Description and Business Overview
Table 134. Convac Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Convac Product
Table 136. Convac Recent Development
Table 137. Mono Hepatitis A Vaccine Market Trends
Table 138. Mono Hepatitis A Vaccine Market Drivers
Table 139. Mono Hepatitis A Vaccine Market Challenges
Table 140. Mono Hepatitis A Vaccine Market Restraints
Table 141. Mono Hepatitis A Vaccine Customers List
Table 142. Mono Hepatitis A Vaccine Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Mono Hepatitis A Vaccine Product Picture
Figure 2. Global Mono Hepatitis A Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Global Mono Hepatitis A Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Mono Hepatitis A Vaccine Report Years Considered
Figure 10. Global Mono Hepatitis A Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Mono Hepatitis A Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Mono Hepatitis A Vaccine Sales 2016-2027 (K Units)
Figure 13. Global Mono Hepatitis A Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Mono Hepatitis A Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Mono Hepatitis A Vaccine Sales Market Share by Region in 2020
Figure 16. Global Mono Hepatitis A Vaccine Revenue Market Share by Region (2016-2021)
Figure 17. Global Mono Hepatitis A Vaccine Revenue Market Share by Region in 2020
Figure 18. Global Mono Hepatitis A Vaccine Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Mono Hepatitis A Vaccine Revenue in 2020
Figure 20. Mono Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Mono Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
Figure 22. Global Mono Hepatitis A Vaccine Sales Market Share by Type in 2020
Figure 23. Global Mono Hepatitis A Vaccine Revenue Market Share by Type (2016-2021)
Figure 24. Global Mono Hepatitis A Vaccine Revenue Market Share by Type in 2020
Figure 25. Global Mono Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
Figure 26. Global Mono Hepatitis A Vaccine Sales Market Share by Application in 2020
Figure 27. Global Mono Hepatitis A Vaccine Revenue Market Share by Application (2016-2021)
Figure 28. Global Mono Hepatitis A Vaccine Revenue Market Share by Application in 2020
Figure 29. United States Mono Hepatitis A Vaccine Sales Growth Rate 2016-2027 (K Units)
Figure 30. United States Mono Hepatitis A Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Mono Hepatitis A Vaccine Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Mono Hepatitis A Vaccine Players Market Share by Revenue in Mono Hepatitis A Vaccine in 2020
Figure 33. United States Mono Hepatitis A Vaccine Revenue Share by Type (2016-2021)
Figure 34. United States Mono Hepatitis A Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Mono Hepatitis A Vaccine Revenue Share by Application (2016-2021)
Figure 36. United States Mono Hepatitis A Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Mono Hepatitis A Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Mono Hepatitis A Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Mono Hepatitis A Vaccine Sales Market Share by Country in 2020
Figure 40. North America Mono Hepatitis A Vaccine Revenue Market Share by Country in 2020
Figure 41. United States Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 42. United States Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Mono Hepatitis A Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Mono Hepatitis A Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Mono Hepatitis A Vaccine Sales Market Share by Country in 2020
Figure 48. Europe Mono Hepatitis A Vaccine Revenue Market Share by Country in 2020
Figure 49. Germany Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Mono Hepatitis A Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Mono Hepatitis A Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Mono Hepatitis A Vaccine Sales Market Share by Region in 2020
Figure 62. Asia Pacific Mono Hepatitis A Vaccine Revenue Market Share by Region in 2020
Figure 63. China Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 74. China Taiwan Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Mono Hepatitis A Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Mono Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Mono Hepatitis A Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 82. Latin America Mono Hepatitis A Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Mono Hepatitis A Vaccine Sales Market Share by Country in 2020
Figure 84. Latin America Mono Hepatitis A Vaccine Revenue Market Share by Country in 20
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs